Literature DB >> 33404724

Severe craniolacunae and upper and lower extremity anomalies resulting from Crouzon syndrome, FGFR2 mutation, and Ser347Cys variant.

Cassio Eduardo Raposo-Amaral1,2, Yuri Moresco Oliveira3, Rafael Denadai3, Cesar Augusto Raposo-Amaral3, Enrico Ghizoni3,4.   

Abstract

Crouzon syndrome is a rare form of syndromic craniosynostosis (SC) characterized by premature fusion of the cranial and facial sutures, elevated intracranial pressure, varying degrees of ocular exposure due to exorbitism, and airway compromise caused by midface retrusion. Craniolacunae and upper and lower extremity anomalies are not frequently found in Crouzon syndrome. We present a girl with Crouzon syndrome caused by c.1040 C > G, p.Ser347Cys, a pathogenic mutation in the FGFR2 gene with atypical characteristics, including craniolacunae resembling severe Swiss cheese type of bone formation, and upper and lower extremity anomalies which are more commonly associated with Pfeiffer syndrome patients. Distinguishing between severe Crouzon syndrome patients and patients who have mild and/or moderate Pfeiffer syndrome can be challenging even for an experienced craniofacial surgeon. An accurate genotype diagnosis is essential to distinguishing between these syndromes, as it provides predictors for neurosurgical complications and facilitates appropriate family counseling related to long-term outcomes.

Entities:  

Keywords:  Craniofacial dyosososis; Crouzon syndrome; Jackson-Weiss syndrome; Pfeiffer syndrome; Syndromic craniosynostosis

Mesh:

Substances:

Year:  2021        PMID: 33404724     DOI: 10.1007/s00381-020-04993-w

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  36 in total

1.  Jackson-Weiss syndrome.

Authors:  M M Cohen
Journal:  Am J Med Genet       Date:  2001-05-15

2.  Trp290Cys mutation of the FGFR2 gene in a patient with severe Pfeiffer syndrome type 2.

Authors:  H Ariga; Y Endo; N Ujiie; T Ishii; N Ishibashi; T Fujita; H Suzuki
Journal:  Pediatr Int       Date:  2001-06       Impact factor: 1.524

3.  Volumetric changes in cranial vault expansion: comparison of fronto-orbital advancement and posterior cranial vault distraction osteogenesis.

Authors:  Christopher A Derderian; Jason D Wink; Jennifer L McGrath; Amy Collinsworth; Scott P Bartlett; Jesse A Taylor
Journal:  Plast Reconstr Surg       Date:  2015-06       Impact factor: 4.730

4.  Treatment of apert syndrome: a long-term follow-up study.

Authors:  Karam A Allam; Derrick C Wan; Krit Khwanngern; Henry K Kawamoto; Neil Tanna; Adam Perry; James P Bradley
Journal:  Plast Reconstr Surg       Date:  2011-04       Impact factor: 4.730

Review 5.  Crouzon syndrome: Genetic and intervention review.

Authors:  N M Al-Namnam; F Hariri; M K Thong; Z A Rahman
Journal:  J Oral Biol Craniofac Res       Date:  2018-08-29

6.  Volumetric analysis of anterior versus posterior cranial vault expansion in patients with syndromic craniosynostosis.

Authors:  Matthew Choi; Roberto L Flores; Robert J Havlik
Journal:  J Craniofac Surg       Date:  2012-03       Impact factor: 1.046

Review 7.  Posterior cranial vault expansion using distraction osteogenesis.

Authors:  Christopher A Derderian; Nicholas Bastidas; Scott P Bartlett
Journal:  Childs Nerv Syst       Date:  2012-08-08       Impact factor: 1.475

8.  Upper extremity anomalies in Pfeiffer syndrome and mutational correlations.

Authors:  Felecia E Cerrato; Laura C Nuzzi; Todd A Theman; Amir Taghinia; Joseph Upton; Brian I Labow
Journal:  Plast Reconstr Surg       Date:  2014-05       Impact factor: 4.730

9.  A case report of a patient with Pfeiffer syndrome, an FGRF 2 mutation (Trp290Cys) and unique ocular anterior segment findings.

Authors:  Gerard P Barry; Betina Mucha-Le Ny; Elaine H Zackai; Lili Grunwald; Brian J Forbes
Journal:  Ophthalmic Genet       Date:  2010-09-01       Impact factor: 1.803

Review 10.  Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis.

Authors:  Saïd C Azoury; Sashank Reddy; Vivek Shukla; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2017-11-02       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.